Ł\”ƒ1-4
|
|
|
- れれ ぜんじゅう
- 5 years ago
- Views:
Transcription
1
2 1 2 (1) 4 (2) 4 (3) 5 (4) 7 (5) 7 (1) 8 (2) 11 (3) 12 (4) 13 (5) 14 (6) 19 (1) 20 (2) 22 (3) 24 (4) (5) 28 (1) 34 (2) 39 (3) 42 (4) 45 (1) 52 (2) 66 (3) 67 (4) 69 (1) 71 (2) 71 (3) 72 (4) 72 (5) 74 (1) 77 (2) 77 (3) 78 (4) 78 (5) 78
3 (6) 78 (1) 80 (2) 80 (3) 80 (4) 80 (1) 84 (2) 86 (3) 86 (4) 88 (1) 93 (2) 93 (3) 93 (1) 97 (2) 97 (3) 98 (1) 99 (2) 100 (3) 102 (4) 103 (5) 106 (6) 106 (7) 106 (8) 107 (9) 108 (10) 108 (1) 110 (2) 111 (3) (1) 115 (2) 117 (3) 119 (4)
4 -1 -
5 (1) (1) (2) (2) (2) ( ) ( (1) ) (2) (2) ( ) ( ) ( ) ) ( ) () ( ) - 2 -
6 - 3 -
7 (2) 24 (1) 2 (1) (2) 0-4 -
8 1) 2) General Risk Manager
9 5 (7 ) (8 (56 ) -6 -
10
11 -8 -
12 -9 -
13 -10-
14 - 11 -
15 -12-
16
17 - 14 -
18 (1)
19 1 1 (2) (3) 1 (4) UMIN (5) (1) (2)
20 - 17 -
21
22 - 19 -
23
24 - 21 -
25 - 22 -
26 - 23 -
27 1 2 3 ID W
28
29 () ( ) ( )600 (100 ) ( )
30 - 27 -
31 - 28 -
32 - 29 -
33 - 30 -
34 - 31 -
35 - 32 -
36 - 33 -
37 Right Right Rightpatient Rightdrug Rightdose Rightroute Righttime Rightrecord 1 2 Right a b e
38
39 1 300 (regular) R U-100 R R N N N (neutral) 30R 30R 30R 100 ml ml ml
40 1 2 3 Total Parenteral NutritionTPN 1 WBCRBCHbHt
41 Trendelenburg 1 2 TPN Closed system TPN TPN TPN 24 TPN CRP CV CV
42 - 39-1) Right Rightpatient Rightdrug Rightdose Rightroute Righttime Rightrecord 2) 3)
43
44
45 ID Rp. recipe: mg mg mg mg200mg
46 Rp. 5mg Rp. 5mg 5 Rp. 1 3 Rp. 25mg Rp. 5 Rp
47 - 44 -
48 THINK
49 - 46 -
50 - 47 -
51 鹿児島大学病院
52 鹿児島大学病院
53 -50-
54
55 ( ) ( : K.T.) ID ( ) 1 ( ) ( )
56 ( )
57
58 ( )
59 - 56 -
60 ( ) ( ) FFP PC ( : K.T.) ID ( ) ( ) (5590) 3 ( )
61 ; 1 10 ( ) Rh (5635) 7 8 ICU (5635)
62 MAP ( 2 ) MAP FFP PC 2ml 1 : ABO,Rh(D) EDTA 5ml 2 : ( ) EDTA ( ) 5ml (ABO Rh(D) ) EDTA ABO Rh(D) 4EDTA Dr 9 10 ( )
63 1 ( ) rpm ml( 1ml) 12 35% A () 2 B () 3 D ( ) 1 ( ) rpm 15 (High2 Start ) A (B ) ( A O B AB Rh(D)
64 3000rpm 510 ABORh(D) 35% ABD () 1 () 1( )1 1 3,400rpm
65
66
67
68
69 1 1 2 ABO Rh(D) Rh(D) Rh(D) Rh(D) ABO RhD ( )
70 ABO O Minor PC/FFP ABO Major ABO Minor RBC PC/FFP RBC PC/FFP A AB O AB A O O A or AB B AB O AB B O O B or AB O A O AB or A AB A O or (A) AB O B O AB or B AB B O or (B) AB O AB O AB AB O O AB ABO Major/Minor RBC PC/FFP A B O AB B A O AB
71
72 ) (NYHA II ) Hb 11g/dl (Ht 30% ) 1 ; (70cc/kg)10% 400cc 2) CPD 21 CPDA 35 MAP MAP 42 FFP FFP 1 Max 1600cc
73 ( ) 3) & ( ) 4) ( ) 1C 2C T3(200) 1V (40mg) 2A20 20ml 1A 14 5) 800ml 1 Hb 13g/dl 2 4 ( ) ( ) EPO
74
75 1 2 ( )
76 (CPR)
77 % ( ) No. No.
78 - 75 -
79 -76-
80 ID ICU
81 X X X X On Off
82 - 79 -
83 - 80 -
84 - 81 -
85 - 82 -
86 - 83 -
87 - 84 -
88 - 85 -
89 X
90 2 Y 3 4 X 5 ( ) L T Y L T Y L T Y L T Y
91 S ( ) ( ) 6) PHS 7PHS
92 cm 1
93 JA
94 1-91 -
95
96
97 (ADL )
98 DL ADL
99
100 HACCP
101 - 98 -
102 - 99 -
103
104
105 1 2 SpO
106
107
108
109
110 2 3 1 AB
111
112 P P
113
114 -111 -
115 THINK 1 ( )
116 1ID ID ID 2FDD FDD FDD
117 StafOffice HUB HUB HUB 3 NEC
118 MRSA VRE MRSA 1) 2 BLS
119 -117-
120 23 10 % CV mmhg 3 IC 4 5 PT-INR K1025 mg
121
122
123
124 H PHS PHS GRM GRM -1-
125 H GRM GRM -1-
126
127
128
129
130
131
132 -129-
133 -130-
134 -131-
135 -132-
136 -133-
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
I
I II 1 2 3 4 5 6 7 8 9 10 11 Rp.1) 50mg 3 3 14 Rp.2) 2.5mg 2 14 Rp.1) 2.5mg 3 2 2:1 14 Rp.) 15g 1 3 28 Rp.2) 50 600mg 1 2 28 12 Rp.1) CR 20mg 1 1 1 14 Rp.2) R 200 1 2 14 Rp.3) 3 1 3 14 Rp.1) 2.5mg 0.4
21 8 20 70 1 1 2 1 1 20 12 22 16201835 2 21 1 21 15001910 3 21 2 23 15001750 4 21 3 23 15002030 5 21 4 27 15102010 6 21 6 15 15002110 7 21 7 27 15001910 2 3 3 21 3 21 4 2 4 1 2 1 2 312 4 3 1 2 3 4 2
untitled
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 -
21 70.9 22 62.9 22 90 80 60 40 23 58 17 42 31 77.5 9 22.5 1 n 40 40 0 2 2 5.0 50 0 3 3 7.5 60 3 12 15 37.5 70 12 5 17 42.5 80 1 1 2 5.0 90 1 0 1 2.5 4
462015 Nagoya community school for health Think health scientifically : the life style and the health condition of seminar participants Hisae USAMI 21 36 67 1/3 21 21 21 1 23 6 68.2 91 43 70 42.56037.5
3 57 210 57 JR 57325 132 28 IC JCT 28 4.1.1 4.1.1 4.1.2 4.1.2 4.1.1 11 35) 4.1.3 4.1.4 4.1.5 77 4.1.1 4.1.2 4.1.3 4.1.2 11 4.1.4 4.1.5 78 298 299 298 325 298 57 299 471 650 299 298 325 400m 640m 4.1.3
137
136 137 16 12 16 17 3 18 138 8 125 144 269 9 125 144 269 10 125 144 269 11 125 144 269 12 125 143 268 13 124 146 270 14 124 147 271 15 124 149 273 16 124 149 273 17 124 152 276 4 1 3 3 3 3 3 3 8 2,641
M1 TSH T 3 T 4 2 T 1 2 Plummer 3 TSH TSH K 5 7 TSH TSH Plummer TSH TSH TSH TSH T 4 T 3 TSH T 4 T 3 TSH TSH or Plummer Plummer or a) 1. 2. 3. b) 1. T 4 T 3 2. TSH 0.1 U/ml 3. TSH TRAb TSAb 4. 1) a) 1
A B A E
10533-68-3955 10533-68-3955 10533-68-3804 RP A-6 10533-68-3804 10533-69-9615 10533-57-2161 B-2 10533-68-2274 10533-68-2221 10533-67-6282 A-6 10533-57-2161 E-3 10533-68-5161 10533-68-3553 D-2 D-2 10533-69-5258
Microsoft Word - 平成24年度医学部卒業試験問題-2.docx
24 2012.10.25 13:00 15 00 5 2 10 20 60 80 110 10 1 6 7 /kg 1 12 20 30:2 AED 3 1 2 119 2 2 2 X X SpO 90% 60mmHg Primary Survey FAST CT 90% 100mmHg FAST 1 2L FAST(Focused assessment with sonography for trauma)
untitled
20,000 20,000 200,000 15,000 15,000 150,000 15,000 15,000 150,000 5,000 5,000 50,000 10/10 800,000 16,000 1,000,000 8,000 800 1/2 1,312,000 1/2 1,312,000 10/10 1,290,000 10/10 120,000 15 16. 9,421,032
d-00
283-0105 298 TEL. 0475-76-0839 FAX. 0475-76-0838 400g 300 4950399167708 14 220g 300 4950399066780 Page 1 300g 200 4950399066766 100 400g 300 4950399167722 350g 160 4950399066735 100 600g 350 4950399167685
untitled
1 ... 3... 3... 3... 4...13...16...18...20...22 2 PTPE 3 PTPE CT Grade 2 A PTPE PTPE 4 A S 3 3 B H3,P1,N1,M1, LM0, R23 15 20gS, ptype 3, 60 x 50mm, pt4b/siurinary bladder, int, INF, ly2, v1, ppm070mm,
12-7 12-7 12-7 12-7 12-8 12-10 12-10 12-10 12-11 12-12 12-12 12-14 12-15 12-17 12-18 10 12-19 12-20 12-20 12-21 12-22 12-22 12-23 12-25 12-26 12-26 12-29 12-30 12-30 12-31 12-33 12-34 12-3 12-35 12-36
SpO2 FIO2 Hypoxic Pulmonary Vasoconstriction HPV 30 FIO2 FIO2 PaCO mL/kg I/E CPAP P
11 a. 2012 1 15 26 http://www1.koalanet.ne.jp/anesth_memorandum/sub19.html SpO2 FIO2 Hypoxic Pulmonary Vasoconstriction HPV 30 FIO2 FIO2 PaCO2 20 30 8 10mL/kg I/E CPAP PEEP 27 b. CO2 ( ) SpO2 COPD PETCO2
untitled
~ ~ ~ ~ ~ 22 14 10 50cm 2124 15 21 29.5 11, 12 12 20 4040 10 60 60 10 20 20 11 ç ç çç 6070 ç ç çç p. ç çç 4.5cm2.5cm 25 http://www.crdc.gifu-u.ac.jp/edsoftol/water/
) km 200 m ) ) ) ) ) ) ) kg kg ) 017 x y x 2 y 5x 5 y )
001 ) g 20 g 5 300 g 7 002 720 g 2 ) g 003 0.8 m 2 ) cm 2 004 12 15 1 3 1 ) 005 5 0.8 0.4 ) 6 006 5 2 3 66 ) 007 1 700 12 ) 008 0.315 ) 009 500 g ) kg 0.2 t 189 kg 17.1 kg 010 5 1 2 cm 3 cm )km 2-1 - 011
01_教職員.indd
T. A. H. A. K. A. R. I. K. O. S. O. Y. O. M. K. Y. K. G. K. R. S. A. S. M. S. R. S. M. S. I. S. T. S. K.T. R. T. R. T. S. T. S. T. A. T. A. D. T. N. N. N. Y. N. S. N. S. H. R. H. W. H. T. H. K. M. K. M.
Microsoft Word - .....J.^...O.|Word.i10...j.doc
P 1. 2. R H C H, etc. R' n R' R C R'' R R H R R' R C C R R C R' R C R' R C C R 1-1 1-2 3. 1-3 1-4 4. 5. 1-5 5. 1-6 6. 10 1-7 7. 1-8 8. 2-1 2-2 2-3 9. 2-4 2-5 2-6 2-7 10. 2-8 10. 2-9 10. 2-10 10. 11. C
... 1... 2... 3... 5... 6... 6... 6... 7... 8... 9... 10... 10...11... 12... 13... 14... 15... 15... 16... 17... 18... 19... 19... 20... 21... 22... 23... 24... 25... 25... 26... 27... 28... 29... 29...
125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10
. (1) 125 1 125 Renagel PB-94 P intact-pth P 1 b c a b 1 18 2 3 3 3 1 P 4 D 1 5 6 7 2 1HIV 2 3 4 5Hb 8.0g/dL ALT 48IU/L 6 7 PB-94 440mg 403mg 1-196 125 2 P 1st washout 2 PB-94 1 2 4 4 P 2.5 5.5mg/dL 1
13,825,228 3,707,995 26.8 4.9 25 3 8 9 1 50,000 0.29 1.59 70,000 0.29 1.74 12,500 0.39 1.69 12,500 0.55 10,000 20,000 0.13 1.58 30,000 0.00 1.26 5,000 0.13 1.58 25,000 40,000 0.13 1.58 50,000 0.00 1.26
endo.PDF
MAP 18 19 20 21 3 1173 MAP 22 700800 106 3000 23 24 59 1984 358 358 399 25 12 8 1996 3 39 24 20 10 1998 9,000 1,400 5,200 250 12 26 4 1996 156 1.3 1990 27 28 29 8 606 290 250 30 11 24 8 1779 31 22 42 9
untitled
. 23 3 2 1 2 3 21 21 22 9 1 23 18 4 5 6 5 40 20 7 1 1 8 9 10 11 12 50cm 13 10 11 14 2011 3 11 15 16 ml mm tel 079-557-0039 & fax 079-557-1888 17 248-240- 98-48- 170-98- 98- ml 85-1,085-18 19 20 21 22 23
1. 1,,,,,,, TUR-P, TUR-Bt 2 3 TUR P,TUR-Bt 4 2, 3. [ ] 1 2,,, 2
![1. 1,,,,,,, TUR-P, TUR-Bt 2 3 TUR P,TUR-Bt 4 2, 3. [ ] 1 2,,, 2](/thumbs/49/25586828.jpg "1. 1,,,,,,, TUR-P, TUR-Bt 2 3 TUR P,TUR-Bt 4 2, 3. [ ] 1 2,,, 2")
2010 1. 2. 3. 4. 5. 6. 7. 7. 8. 1 1. 1,,,,,,, TUR-P, TUR-Bt 2 3 TUR P,TUR-Bt 4 2, 3. [ ] 1 2,,, 2 2,,,,,, NYHA,,,,, Hugh-Jones,,,,,,,,,,, 10 / l PT-INR1.5 APTT 50 NSAIDs 4 1 12 24 12 5PT-INR PT INR 3
Microsoft Word - 表紙資料２－４
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
A(6, 13) B(1, 1) 65 y C 2 A(2, 1) B( 3, 2) C 66 x + 2y 1 = 0 2 A(1, 1) B(3, 0) P 67 3 A(3, 3) B(1, 2) C(4, 0) (1) ABC G (2) 3 A B C P 6
1 1 1.1 64 A6, 1) B1, 1) 65 C A, 1) B, ) C 66 + 1 = 0 A1, 1) B, 0) P 67 A, ) B1, ) C4, 0) 1) ABC G ) A B C P 64 A 1, 1) B, ) AB AB = 1) + 1) A 1, 1) 1 B, ) 1 65 66 65 C0, k) 66 1 p, p) 1 1 A B AB A 67
ご案内
14 NST 2008 12 20 14001800 2 2 3 TEL 0432961111 NST 1 PC 2 5 3 8 3 Power Point PC 4 USB CDRRW 5 40 6 PC OS Windows XP 7 PC PC 1 Windows Power Point 2000/2002/2003/2007 2 OS 3 XGA1024768 4 5 6 Mac OS Windows
EPSON エプソンプリンタ共通 取扱説明書 ネットワーク編
K L N K N N N N N N N N N N N N L A B C N N N A AB B C L D N N N N N L N N N A L B N N A B C N L N N N N L N A B C D N N A L N A L B C D N L N A L N B C N N D E F N K G H N A B C A L N N N N D D
ありがとうございました
- 1 - - 2 - - 3 - - 4 - - 5 - 1 2 AB C A B C - 6 - - 7 - - 8 - 10 1 3 1 10 400 8 9-9 - 2600 1 119 26.44 63 50 15 325.37 131.99 457.36-10 - 5 977 1688 1805 200 7 80-11 - - 12 - - 13 - - 14 - 2-1 - 15 -
EPSON エプソンプリンタ共通 取扱説明書 ネットワーク編
K L N K N N N N N N N N N N N N L A B C N N N A AB B C L D N N N N N L N N N A L B N N A B C N L N N N N L N A B C D N N A L N A L B C D N L N A L N B C N N D E F N K G H N A B C A L N N N N D D
公務員人件費のシミュレーション分析
47 50 (a) (b) (c) (7) 11 10 2018 20 2028 16 17 18 19 20 21 22 20 90.1 9.9 20 87.2 12.8 2018 10 17 6.916.0 7.87.4 40.511.6 23 0.0% 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2.0% 4.0% 6.0% 8.0%
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 A B (A/B) 1 1,185 17,801 6.66% 2 943 26,598 3.55% 3 3,779 112,231 3.37% 4 8,174 246,350 3.32% 5 671 22,775 2.95% 6 2,606 89,705 2.91% 7 738 25,700 2.87% 8 1,134
橡hashik-f.PDF
1 1 1 11 12 13 2 2 21 22 3 3 3 4 4 8 22 10 23 10 11 11 24 12 12 13 25 14 15 16 18 19 20 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 144 142 140 140 29.7 70.0 0.7 22.1 16.4 13.6 9.3 5.0 2.9 0.0
198
197 198 199 200 201 202 A B C D E F G H I J K L 203 204 205 A B 206 A B C D E F 207 208 209 210 211 212 213 214 215 A B 216 217 218 219 220 221 222 223 224 225 226 227 228 229 A B C D 230 231 232 233 A
1
1 2 3 4 5 (2,433 ) 4,026 2710 243.3 2728 402.6 6 402.6 402.6 243.3 7 8 20.5 11.5 1.51 0.50.5 1.5 9 10 11 12 13 100 99 4 97 14 A AB A 12 14.615/100 1.096/1000 B B 1.096/1000 300 A1.5 B1.25 24 4,182,500
05[ ]戸田(責)村.indd
![05[ ]戸田(責)村.indd](/thumbs/91/106164845.jpg "05[ ]戸田(責)村.indd")
147 2 62 4 3.2.1.16 3.2.1.17 148 63 1 3.2.1.F 3.2.1.H 3.1.1.77 1.5.13 1 3.1.1.05 2 3 4 3.2.1.20 3.2.1.22 3.2.1.24 3.2.1.D 3.2.1.E 3.2.1.18 3.2.1.19 2 149 3.2.1.23 3.2.1.G 3.1.1.77 3.2.1.16 570 565 1 2
ネットショップ・オーナー２ ユーザーマニュアル
1 1-1 1-2 1-3 1-4 1 1-5 2 2-1 A C 2-2 A 2 C D E F G H I 2-3 2-4 2 C D E E A 3 3-1 A 3 A A 3 3 3 3-2 3-3 3-4 3 C 4 4-1 A A 4 B B C D C D E F G 4 H I J K L 4-2 4 C D E B D C A C B D 4 E F B E C 4-3 4
/9/ ) 1) 1 2 2) 4) ) ) 2x + y 42x + y + 1) 4) : 6 = x 5) : x 2) x ) x 2 8x + 10 = 0
1. 2018/9/ ) 1) 8 9) 2) 6 14) + 14 ) 1 4 8a 8b) 2 a + b) 4) 2 : 7 = x 8) : x ) x ) + 1 2 ) + 2 6) x + 1)x + ) 15 2. 2018/9/ ) 1) 1 2 2) 4) 2 + 6 5) ) 2x + y 42x + y + 1) 4) : 6 = x 5) : x 2) x 2 15 12
untitled
61 62 18 19 10 20 21 22 63 23 24 64 65 EU 100 66 ? ( )? 1999 2 22? 1 1? 67 9 0 6 8 9 1 1 1 Java? 1 2 3 5 4 9 8 2 3 5 II 4 4 4 5 II 1 I 68 II (?) 9 2 2 1 1 2 2 3 4 4 5 5 5 3 4 11 2 1 2 69 10 2F 2F 6 2 11
“÷Œò›ï49
49 Epimedium chlorandrum Stearn 20 6 28 2 6 1. 2. 3. 4. 5. 6. 5653 11,0021,441 4 3 100 10 120 9 10 14 15 14 IT21 21 25 IT18 2020 33 6 6 2 3 6 Outstanding Student Award 6 7 14 17 18 21 19 19 20 20 21 22
untitled
-- -- -3- % % % 6% % % 9 66 95 96 35 9 6 6 9 9 5 77 6 6 5 3 9 5 9 9 55 6 5 9 5 59 () 3 5 6 7 5 7 5 5 6 6 7 77 69 39 3 6 3 7 % % % 6% % % (: ) 6 65 79 7 3 36 33 9 9 5 6 7 3 5 3 -- 3 5 6 76 7 77 3 9 6 5
untitled
NO. 2007 10 10 34 10 10 0570-058-669 http://www.i-nouryoku.com/index.html (40 ) () 1 NO. 2007 10 10 2.2 2.2 130 70 20 80 30 () () 9 10 () 78 8 9 () 2 NO. 2007 10 10 4 7 3 NO. 2007 10 10 40 20 50 2 4 NO.
L- 19 L L- L-
0131001 15 1 31 49 35 145 14 5 19 4 23 15 3 10 7 15 634 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 L- 19 L- 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49
訪問入浴Ｑ＆Ａ PDFファイ ル httpwww.care-mirai.commiraihomehelpe_buth.html.docx
4 450kg500kg 185cm 95kg 100kg 185 ( ) Vision , 40 8/138/15 1/11/3 1 13,000 11,700 9,500 3,500 13,000 11,700 9,500 3,500 http://www.care-mirai.com 1 37 38 1 1,000PPM soda premium 1,100ppm http://www.care-mirai.com/mirai/carbonated.html
2002 715 02-13M 1. 200110 024 2. 3. 4. 100 60 5. 6. 2002715 1 1 1 4 9 9 12 12 13 14 14 15 15 17 17 18 22 22 23 25 25 25 29 200110 024 3 1 1965 500 800 3,000 2,000 1 1 60 2.84 1.173 1 2002 71 1,726 1,085
26 () () (1) (350ml ) (4 ) (2) 10 (3) RC
27 2015 27 2 3 ( 1.0 ) 1. 2. 2015 6 13 ( ) 2015 6 14 ( ) : (URL: http://www.kagakukan.sendai-c.ed.jp) 981 0903 4 1 Tel: 022-276-2201, Fax: 022-276-2204 3. : : : 2015 5 6 ( ) (ID ) 2015 5 11 ( ) () 2015
橡matufw
3 10 25 3 18 42 1 2 6 2001 8 22 3 03 36 3 4 A 2002 2001 1 1 2014 28 26 5 9 1990 2000 2000 12 2000 12 12 12 1999 88 5 2014 60 57 1996 30 25 205 0 4 120 1,5 A 1995 3 1990 30 6 2000 2004 2000 6 7 2001 5 2002
O
11 2 1 2 1 1 2 1 80 2 160 3 4 17 257 1 2 1 2 3 3 1 2 138 1 1 170 O 3 5 1 5 6 139 1 A 5 2.5 A 1 A 1 1 3 20 5 A 81 87 67 A 140 11 12 2 1 1 1 12 22 1 10 1 13 A 2 3 2 6 1 B 2 B B B 1 2 B 100 B 10 B 3 3 B 1
, 360ml P , 360ml P , 360ml P , 40, 720ml P , 14, 2
3-1 3-1 20 2600, 20, 360ml P.35 3-2 3-2 16 2700, 16, 280ml P.35 3-3 3-3 20 2600, 20, 360ml P.35 3-4 3-4 19 2600, 19, 340ml P.35 3-5 3-5 20 2900, 20, 360ml P.35 3-6 3-6 18 3000, 18, 320ml P.35 3-7 3-7 18
(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..
... -1... -1... -2... -6.... -1 (1)... -1 1)... -1 2)... -14 (2)... -19 (3)... -52 (4)... -18 (5)... -136.... -196 (1)... -196 (2) b... -224 (3)... -233.... -251.... -286.... -289 (1)... -289 (2)... -32
- 1 - - 0.5%5 10 10 5 10 1 5 1
- - - 1 - - 0.5%5 10 10 5 10 1 5 1 - 2 - - - - A B A A A B A B B A - 3 - - 100 100 100 - A) ( ) B) A) A B A B 110 A B 13 - 4 - A) 36 - - - 5 - - 1 - 6-1 - 7 - - 8 - Q.15 0% 10% 20% 30% 40% 50% 60% 70%
rule2018.dvi
30 2018 30 4 21 ( RC ) 1. 2. 2018 6 16 ( ) 2018 6 17 ( ) : (URL: http://www.kagakukan.sendai-c.ed.jp) 981 0903 4 1 Tel: 022-276-2201, Fax: 022-276-2204 3. : : : 2018 5 11 ( ) (ID ) 2018 5 14 ( ) () 2018
2 章 +αの 情 報 に 着 目 する! 1 血 球 算 定 検 査 結 果 2 生 化 学 検 査 結 果 手 がかりに 乏 しいのも+α 1 症 例 をみてみよう! 1 60 吉 見 祐 輔 1 2 11percutaneous coronary intervention PCI104 38.
2 章 +αの 情 報 に 着 目 する! 1 血 球 算 定 検 査 結 果 2 生 化 学 検 査 結 果 手 がかりに 乏 しいのも+α 1 症 例 をみてみよう! 1 60 吉 見 祐 輔 1 2 11percutaneous coronary intervention PCI104 38.1 130 75mmHg 83 16 SpO 297 1 3 WBCL RBC10 4 L Hb g
平成25年度調理師試験問題
25 15 60 HB 2 1 1 2 36 1961 46 1971 56 1981 3 1991 3 4-1 - 5 6 7 8 6 2 12 31 1 15 1 15 4 15 4 15-2 - 9-3 - 10 11 12 13 3-4 - 14 腿 15 16 WHO 22 2010 17 18 1-5 - 19 1 g 4 kcal 4 kcal 9 kcal 9 kcal 20 21
II (No.2) 2 4,.. (1) (cm) (2) (cm) , (
II (No.1) 1 x 1, x 2,..., x µ = 1 V = 1 k=1 x k (x k µ) 2 k=1 σ = V. V = σ 2 = 1 x 2 k µ 2 k=1 1 µ, V σ. (1) 4, 7, 3, 1, 9, 6 (2) 14, 17, 13, 11, 19, 16 (3) 12, 21, 9, 3, 27, 18 (4) 27.2, 29.3, 29.1, 26.0,
15 7 26 1,276 3,800 1 16 15 1 2 3 4 2
1 15 7 26 1,276 3,800 1 16 15 1 2 3 4 2 JA 3 4 2 1 3 2001 1981 6 10% 10 30% 1 2 JA JA 2 4 JA 2 1 2 1 2 1 2 1 2 1 2 7 5 1 1 1 3 1 6 1 1 2 2 1 7 2 3 3 53 1 2000 30 8 250 53 435 20 35 3 1 8 2 4 3 2 2 232
EX-word_Library_JA
JA 2 3 4 5 14 7 1 2 6 3 1 2 7 3 8 27 1 2 3 1 2 3 9 1 2 3 1 2 3 10 12 13 14 11 1 12 1 2 13 1 2 3 25 14 1 2 3 25 15 1 2 3 25 16 1 2 3 25 17 1 2 3 25 18 1 2 3 4 25 19 1 2 3 4 25 20 1 2 21 3 4 25 22 1 2 3
324.pdf
50 50 10 30 11 26 12 27 14 16 27 18 20 21 22 22 22 22 23 24 24 1 No.324 JA 2 85 69 20 12 81 18 12 22 93 10 31 3 50 50 30 30 50 22 27 27 10 16 14 52 10 62 15 64 25 24 50 4 25 23 27 5 10 11 25 6 11 49 10
『こみの株式会社』の実践
2003 . JA JA A JA 811 2005/8/11 1003 452 10 960 28 2005/8/11 1003 452 6 120 29 2005/8/11 2003 151 10 420 33 2005/8/11 2003 211 3 180 31 2005/8/11 2003 211 3 150 32 827 400 5 80 221 2005/6/25 900 3 300
